Galmed Pharmaceuticals Earning Date (GLMD)

USA |NASDAQ |USD |ADR

GLMD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 16, 2022 Dec 2021 $-0.33 - $-0.48
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 16, 2022 Dec 2021 $0.00 - $0.00

Galmed Pharmaceuticals's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 2021.

GLMD Earnings Date & History Chart

GLMD Earnings & Revenue Forecast

GLMD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.33 $-0.41 $-0.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.39 $-1.54 $-1.19
Dec 2022 5 $-1.35 $-1.89 $-0.90

GLMD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.33 $-0.33 $-0.36
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.39 $-1.39 $-1.49
Dec 2022 0 / 0 $-1.35 $-1.35 $-1.40

GLMD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Dec 2022 5 $0.00 $0.00 $0.00

GLMD Earnings Date & Revenue History

GLMD Earnings History

|
Show More
Show More

GLMD Revenue History

|
Show More
Show More

Galmed Pharmaceuticals Next Earnings Date & Report

GLMD Next Earnings Date & Report Preview: Dec 2021 (FQ)

GLMD's next earnings date is Wednesday, Mar 16, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Galmed Pharmaceuticals's next quarterly earnings is $-0.33, with a low EPS estimation of $-0.41, and a high estimation of $-0.24.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.33, the last 2 month trend is $-0.33, and the 3 month trend is $-0.36.

Based on analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Galmed Pharmaceuticals Previous Earnings Dates & Reports

GLMD Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Galmed Pharmaceuticals's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.

GLMD Previous Earnings Date & Report Recap: Dec 2020 (FY)

Galmed Pharmaceuticals's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.

GLMD's earnings per share (EPS) was $-1.35, missing the consensus analysts forecast of $-1.25 by 8.00% , and lower than the previous year's EPS (Dec 2019) by 39.18%.

Revenues were $0.00.

The company reported a net income of $-28.77M.

Galmed Pharmaceuticals reported a free cash flow of $-26.33M for its fiscal year, compared to $-14.95M a year ago.

The company ended the fiscal year with $216.00K in total debt, a decrease of -38.64% compared to the previous year.